MPG.eBooks - Search Results

Cover Image

21

Bioabsorbable stents for adults with coronary artery disease : a review of the clinical effectiveness, cost-effectiveness, and guidelines

Published 2013

Canadian Agency for Drugs and Technologies in Health

Cover Image

22

Computed tomography angiography versus computed tomography for the diagnosis and management of hyperacute stroke : a review of comparative clinical evidence and guidelines

Published 2013

Canadian Agency for Drugs and Technologies in Health

Cover Image

23

CPAP treatment for adults with obstructive sleep apnea : review of the clinical and cost-effectiveness and guidelines

Published 2013

Canadian Agency for Drugs and Technologies in Health

Cover Image

24

Fondaparinux versus enoxaparin for acute coronary syndrome : a review of the comparative clinical effectiveness and cost-effectiveness

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

25

Mismatch repair deficiency testing for patients with colorectal cancer : a clinical and cost-effectiveness evaluation

by Assasi, Nazila, Blackhouse, Gord, Campbell, Kaitryn, Weeks, Laura Christine
Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

26

Monitoring for atrial fibrillation in discharged stroke and transient ischemic attack patients : a clinical and cost-effectiveness analysis and review of patient preferences

by De Angelis, Gino
Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

27

Certolizumab pegol (Cimzia) (subcutaneous injection)

Published 2017

CADTH

Cover Image

28

Everolimus (Afinitor) (oral tablets)

Published 2017

CADTH

Cover Image

29

Composite resin versus amalgam for dental restorations : a health technology assessment -- project protocol

Published 2017

CADTH

Cover Image

30

Dialysis modalities for the treatment of end-stage kidney disease : recommendations

Published 2017

CADTH

Cover Image

31

Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration : project protocol

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

32

Third-line drugs for type 2 diabetes -- project protocol

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

33

CHAD65 and CHA2DS2-VASc risk stratification tools for patients with atrial fibrillation : a review of clinical effectiveness and guidelines

by Banerjee, Srabani, Picheca, Lory
Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

34

Education and assessment for overdose prevention : a review of the clinical evidence and guidelines

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

35

Antibiotic impregnated cement for primary hip or knee arthroplasty : a review of the clinical and cost-effectiveness

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

36

Attention-deficit/hyperactivity disorder medication switching for patients with aggression or mood changes secondary to current medication : a review of clinical effectiveness and...

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

37

Diagnosing, screening, and monitoring depression in the elderly : a review of guidelines

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

38

Antidepressants in elderly patients with depression and dementia : a review of clinical effectiveness and guidelines

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

39

Comparative value of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) testing in combination versus individually for the diagnosis of undifferentiated patients wit...

by Assasi, Nazila
Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

40

Discontinuation strategies for patients with long-term benzodiazepine use : a review of clinical evidence and guidelines

Published 2015

Canadian Agency for Drugs and Technologies in Health

1
2
3
4
5
6
7
8
9
10
11